Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC LYMPHOCYTIC B-LEUKEMIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03343678
What this trial is testing

This Study in Patients With Chronic Lymphocytic Leukaemia is Done to Determine a Safe and Effective Dose of BI 836826 in Combination With Venetoclax

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Boehringer Ingelheim
Early research (Phase 1)Study completedNCT01351935
What this trial is testing

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Who this might be right for
B Cell Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaWaldenstrom Macroglobulinemia
Celgene 113
Early research (Phase 1)Study completedNCT03019055
What this trial is testing

Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, B-CellChronic Lymphocytic Leukemia+1 more
Medical College of Wisconsin 26
Early research (Phase 1)Study completedNCT01292135
What this trial is testing

Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Pharmacyclics LLC. 33
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Post-approval studies (Phase 4)Looking for participantsNCT06651970
What this trial is testing

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Who this might be right for
Chronic Lymphocytic LeukaemiaModerate to Severe Cardiac Impairment
AstraZeneca 60
Testing effectiveness (Phase 2)WithdrawnNCT00485966
What this trial is testing

Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Cylene Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00026351
What this trial is testing

Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Pharmatech Oncology
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Post-approval studies (Phase 4)Study completedNCT00802737
What this trial is testing

Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 29
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Early research (Phase 1)Active Not RecruitingNCT04629729
What this trial is testing

FT819 in Subjects With B-cell Malignancies

Who this might be right for
Lymphoma, B-CellChronic Lymphocytic LeukemiaPrecursor B-Cell Acute Lymphoblastic Leukemia
Fate Therapeutics 54
Early research (Phase 1)UnknownNCT03685786
What this trial is testing

CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCT

Who this might be right for
Leukemia, Lymphocytic, Acute, B-CellLeukemia, Lymphocytic, Chronic, B-CellLymphoma, B-Cell
Shenzhen Second People's Hospital 20
Early research (Phase 1)Study completedNCT02128945
What this trial is testing

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies

Who this might be right for
Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
University Hospital, Caen 10
Testing effectiveness (Phase 2)WithdrawnNCT04660045
What this trial is testing

Early Intervention With Acalabrutinib in Patients With High Risk CLL

Who this might be right for
Chronic Lymphocytic LeukemiaCLL/SLL
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT00558675
What this trial is testing

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Who this might be right for
Hematological MalignancyLeukemiaLymphoma+1 more
Mirror Biologics, Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT05281809
What this trial is testing

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

Who this might be right for
B-Cell LymphomaB Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+6 more
John Lister 30
Large-scale testing (Phase 3)Study completedNCT01578707
What this trial is testing

Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Pharmacyclics LLC. 391
Early research (Phase 1)Study completedNCT04210219
What this trial is testing

JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLC 85
Early research (Phase 1)Active Not RecruitingNCT05688475
What this trial is testing

A Rollover Study of CC-122

Who this might be right for
Non-Hodgkin Lymphoma
Bristol-Myers Squibb 12
Next Page